112283 ⎘
Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
Sub-classes:TRANSGENIC T CELL AND CHIMERIC ANTIGEN RECEPTOR T CELL COMPOSITIONS AND RELATED METHODS
#2TRANSCRIPTION REGULATING NUCLEOTIDE SEQUENCES AND METHODS OF USE
#3GUIDE RNAS, VECTORS, AND VIRIONS FOR TARGETING MUTATIONS IN THE PLN GENE
#4METHODS FOR MESSENGER RNA TAILING
#5COMPOSITIONS FOR ACTIVATING AND SILENCING GENE EXPRESSION
#6VGLL4 WITH UCP-1 CIS-REGULATORY ELEMENT AND METHOD OF USE THEREOF
#7Primary NK CAR Constructs And Methods
#8ERYTHROPARVOVIRUS WITH A MODIFIED GENOME FOR GENE THERAPY
#9Chemically Induced Proximity Systems
#10GENETIC TARGETING OF CELLULAR OR NEURONAL SUB-POPULATIONS
#11ADENOVIRAL EXPRESSION VECTOR AND METHODS AND CELL LINES FOR PRODUCTION
#12CODON-OPTIMIZED ACID ALPHA-GLUCOSIDASE EXPRESSION CASSETTES AND METHODS OF USING SAME
#13TEMPERATURE-SENSITIVE INDUCTION OF THE MYOGENIC AND/OR ADIPOGENIC PROGRAMME IN CELLS FOR THE PRODUCTION OF MUSCLE AND/OR ADIPOSE TISSUE
#14SYNTHETIC TARGETERS OF UBIQUITINATION AND DEGRADATION (STUDS) AS EFFECTORS FOR FEEDBACK CONTROL IN MAMMALIAN CELLS
#15SYSTEMS AND METHODS FOR THE TARGETED PRODUCTION OF A THERAPEUTIC PROTEIN WITHIN A TARGET CELL
#16OPTOGENETIC CONTROL OF MICROBIAL CO-CULTURE POPULATIONS
#17NFAT-RESPONSIVE REPORTER SYSTEMS FOR ASSESSING CHIMERIC ANTIGEN RECEPTOR ACTIVATION AND METHODS OF MAKING AND USING THE SAME
#18GENE THERAPY BASED ADMINISTRATION OF LENTIVIRUS VECTOR FOR TREATING HEMOGLOBINOPATHIES
#19REGULATED VIRAL DELIVERY SYSTEMS AND THEIR USES
#20METHODS OF ALTERING GENE EXPRESSION BY PERTURBING TRANSCRIPTION FACTOR MULTIMERS THAT STRUCTURE REGULATORY LOOPS
#21ENGINEERED CELLS FOR PRODUCING OF THERAPEUTIC AGENTS TO BE DELIVERED BY A HYBRID BIOELECTRONIC DEVICE
#22Compositions and Methods for Treating Hereditary Angioedema
#23SYSTEMS AND METHODS FOR REGULATING GENE EXPRESSION OR ACTIVITY
#24TRANSPOSON-BASED VECTORS AND USES
#25EXPRESSION SYSTEM AND METHOD FOR CONTROLLING A NETWORK IN A CELL AND CELL COMPRISING THE EXPRESSION SYSTEM
#26A TUNABLE PHOSPHORYLATION-BASED FEEDBACK CONTROLLER OF MAMMALIAN GENE EXPRESSION
#27Genetic Construct
#28METHOD FOR ACTIVATING EXPRESSION OF GAMMA-GLOBIN GENE, AND COMPOSITION
#29SYNTHETIC EXPRESSION SYSTEMS
#30METHODS AND COMPOSITIONS FOR THE PRODUCTION OF ACETYL-COA DERIVED PRODUCTS
#31METHODS FOR IMPROVED DELIVERY OF THERAPEUTIC AGENTS
#32TRANSGENIC T CELL AND CHIMERIC ANTIGEN RECEPTOR T CELL COMPOSITIONS AND RELATED METHODS
#33OPTOGENETIC CONTROL OF MICROBIAL CO-CULTURE POPULATIONS
#34Co-regulatory sequences based on tetracycline and Cumate
#35SYSTEMS AND METHODS FOR GENERATING GENETIC INCOMPATIBILITY
#36TOOLS AND METHODS FOR USING CELL DIVISION LOCI TO CONTROL PROLIFERATION OF CELLS
#37Primary NK CAR Constructs And Methods
#38VGLL4 WITH UCP-1 CIS-REGULATORY ELEMENT AND METHOD OF USE THEREOF
#39SINGLE INPUT MULTIPLEX DECISION SYSTEMS AND METHODS OF USING THE SAME
#40COMPOSITIONS AND PRODUCTION OF NICKED CLOSED-ENDED DNA VECTORS
#41REGULATABLE EXPRESSION USING ADENO-ASSOCIATED VIRUS (AAV)
#42NOVEL NUCLEIC ACID MODIFIERS
#43GENE THERAPY METHODS
#44GRNA TARGETING MIR-29B, AAV8-CRISPER/CAS9 SYSTEM AND USE THEREOF
#45GENETIC TARGETING OF CELLULAR OR NEURONAL SUB-POPULATIONS
#46Instruments, modules, and methods for improved detection of edited sequences in live cells
#47Adenoviral expression vector and methods and cell lines for production
#48Codon-optimized acid alpha-glucosidase expression cassettes and methods of using same
#49Molecular tools and methods for transgene integration and their transposition dependent expression
#50Riboregulated Switchable Feedback Promoter Systems and Methods
#51Enhanced promoter
#52Expression from transposon-based vectors and uses
#53COMPOSITIONS AND METHODS FOR THE TREATMENT OF STARGARDT DISEASE
#54Methods and compositions for treatment of ocular disorders and blinding diseases
#55PROMOTER AND CARRIER COMPOSED OF SAME AND APPLICATION THEREOF
#56VGLL4 with UCP-1 cis-regulatory element and method of use thereof
#57PROMOTER VARIANTS
#58Genome engineering with type I CRISPR systems in eukaryotic cells
#59Methods and Compositions for Engineering Synthetic Bioswitches for Remote Control of Biological Activity
#60RP2 and RPGR vectors for treating X-linked retinitis pigmentosa
#61Gene therapy vectors for treatment of Danon disease
#62TRANSCRIPTION SYSTEM
#63Methods of altering gene expression by perturbing transcription factor multimers that structure regulatory loops
#64PDL1 block CAR-T transgenic vector for suppressing immune escape, preparation method thereof, and application of the same
#65NOVEL SACCHAROMYCES CEREVISIAE EXPRESSION SYSTEM AND CONSTRUCTION METHOD THEREOF
#66Expression from transposon-based vectors and uses
#67Transgenic T cell and chimeric antigen receptor T cell compositions and related methods
#68ULTRASOUND METHOD
#69Vector
#70Methods and compositions for treatment of ocular disorders and blinding diseases
#71Reporter system for detecting and targeting activated cells
#72Genome engineering with Type I CRISPR systems in eukaryotic cells
#73Promoter variants
#74COMPOSITIONS AND METHODS FOR TREATMENT OF INSULIN-DEPENDENT DIABETES MELLITUS
#75RP2 and RPGR vectors for treating X-linked retinitis pigmentosa
#76CONDITIONAL RESCUE SYSTEM, CELLS, AND METHODS
#77Virus-based expression vectors and uses thereof
#78Constructs containing multiple expression cassettes for cancer therapy
#79Genetically modified major histocompatibility complex animals
#80Synthetic transcriptional control elements and methods of generating and using such elements
#81Reversible gene expression
#82Light-switchable gene expression system
#83Promoters exhibiting endothelial cell specificity and methods of using same
#84Genetically modified major histocompatibility complex animals
#85Promoters exhibiting endothelial cell specificity and methods of using same
#86Selective infarcted-tissue-targeting bacteria and use thereof
#87Simian Adenovirus Vectors and Methods of Use
#88GENE THERAPY VECTOR FOR TREATMENT OF STEROID GLAUCOMA
#89PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME
#90Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small-molecule regulator
#91SYSTEM FOR PACKAGING HIGH-CAPACITY ADENOVIRUSES
#92Controlled activation of non-LTR retrotransposons in mammals
#93Selectively replicating viral vectors
#94Diphtheria toxin first open reading frame operably linked to an H19 promoter and a diphtheria toxin second open reading frame operably linked to an IGF-II promoter as nucleic acid construct
#95Sequence capable of enhancing the expression of gene under moderately low temperature
#96Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor GM-CSF in tumor cells and uses thereof
#97Replication-competent anti-cancer vectors
#98Promoters exhibiting endothelial cell specificity and methods of using same
#99Simian adenovirus vectors and methods of use
#100AGENTS FOR PRE-SYMPTOMATIC DETECTION AND THERAPEUTIC TARGETING OF ALZHEIMER'S DISEASE AND DOWN SYNDROME IN HUMANS
#101Epididymal lipocalin gene and uses thereof
#102Pan cancer oncolytic vectors and methods of use thereof
#103Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small-molecule regulator
#104Method for growing stem cells on genetically modified supporter cells
#105Growth differentiation factor promoter and uses therefor
#106Multiple gene transcription activity assay system
#107Cell-specific molecule and method for importing DNA into osteoblast nuclei
#108Method to inhibit cell growth using oligonucleotides
#109Adiponectin promoter and use thereof
#110Gene transcription and ionizing radiation: methods and compositions
#111Replication-competent anti-cancer vectors
#112BMP-2 estrogen responsive element and methods of using the same
#113Molecular switch for regulating mammalian gene expression
#114Control of gene expression in eukaryotic cells
#115Pan cancer oncolytic vectors and methods of use thereof
#116Promoters exhibiting endothelial cell specificity and methods of using same
#117Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans